Skip to content

Randomized controlled trial of acupuncture on POI

Randomized controlled trial of effectiveness and safety of acupuncture versus HRT on POI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004760
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ovarian insufficiency

Interventions

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged between 25-40, 2. Haven't received any other treatments in the last two months before enrollment; 3. No pregnancy plan in six months; 4. Patients voluntarily participate in the study; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are pregnant; 2. Patients with primary amenorrhea; 3. Congenital reproductive organ abnormalities; 4. Patients with internal diseases which can affect reproductive hormones, such as thyroid disease, SLE, etc.; 5. Patients with other serious internal diseases and mental diseases; 6. Patients with unilateral or bilateral oophorectomy; 7. Those who are unable to tolerate the tests or treatments during the course of this study; 8. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Serum Anti Mullerian Hormone, AMH;Follicle Stimulating Hormone, FSH;

Secondary

MeasureTime frame
Menstrual condition;Follicle Stimulating Hormone/Luteinizing hormone , FSH/LH;Serum estradiol, E2;Kupperman index;Luteinizing hormone, LH;

Countries

China

Contacts

Public ContactChen Lifang

The Third Affiliated Hospital of Zhejiang Chinese Medical University

clfang@163.com+86 13957157278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026